ArticleCureus2026
Racial and Ethnic Disparities Associated With the Use of Opioids for Chronic Non-cancer Pain.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic non-cancer pain (CNCP) affects a substantial proportion of adults in the United States and is commonly managed using both opioid and non-opioid therapies. This study examined racial and ethnic disparities associated with opioid use for CNCP using nationally representative data. With national efforts and evolving clinical guidelines to reduce opioid use for non-cancer pain, it is not clear if these efforts have helped everyone equally. The objective of the study was to examine racial and ethnic disparities associated with opioid use as a treatment strategy for CNCP. A serial cross-sectional study was conducted using the nationally representative Medical Expenditure Panel Survey (MEPS) data (2016-2021) to estimate opioid and non-opioid treatment choices for CNCP. Racial/ethnic disparities were evaluated by comparing non-Hispanic White patients (whites) with non-Hispanic Black patients (blacks), non-Hispanic Asian/Native American/other/multiple patients (Asians/others), and Hispanic patients. In a sample of 7521 individuals (weighted sample = 14.12M) from 2016 to 2021 with CNCP, our study unveiled that 5.51% utilized opioid therapies while 94.49% utilized non-opioid treatments. Results indicated racial disparities were evident even with declining opioid utilization, as Black individuals exhibited lower estimated odds of opioid utilization (OR = 0.759, 95% CI: 1.240-1.686, p < 0.05) compared to the White population. Other comparisons were not significant. Results revealed significant racial disparities in opioid utilization for CNCP, with Black patients less likely to receive opioid therapy compared to White patients, despite overall declining opioid use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.